246 related articles for article (PubMed ID: 22334717)
1. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
2. FGF23 fails to inhibit uremic parathyroid glands.
Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
[TBL] [Abstract][Full Text] [Related]
3. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
4. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
[TBL] [Abstract][Full Text] [Related]
5. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
[TBL] [Abstract][Full Text] [Related]
6. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
8. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Drüeke TB
Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
Miller G; Davis J; Shatzen E; Colloton M; Martin D; Henley CM
Nephrol Dial Transplant; 2012 Jun; 27(6):2198-205. PubMed ID: 22036941
[TBL] [Abstract][Full Text] [Related]
10. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
[TBL] [Abstract][Full Text] [Related]
11. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
[TBL] [Abstract][Full Text] [Related]
13. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
Brown AJ; Ritter CS; Finch JL; Slatopolsky EA
Kidney Int; 1999 Apr; 55(4):1284-92. PubMed ID: 10200992
[TBL] [Abstract][Full Text] [Related]
14. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
Chen XJ; Chen X; Wu WJ; Zhou Q; Gong XH; Shi BM
J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
[TBL] [Abstract][Full Text] [Related]
15. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
[TBL] [Abstract][Full Text] [Related]
17. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
Cozzolino M; Lu Y; Finch J; Slatopolsky E; Dusso AS
Kidney Int; 2001 Dec; 60(6):2109-17. PubMed ID: 11737585
[TBL] [Abstract][Full Text] [Related]
18. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
Lafage-Proust MH
Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
[TBL] [Abstract][Full Text] [Related]
19. Influence of parathyroid mass on the regulation of PTH secretion.
Lewin E; Olgaard K
Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
[TBL] [Abstract][Full Text] [Related]
20. FGF23 and the parathyroid.
Silver J; Naveh-Many T
Adv Exp Med Biol; 2012; 728():92-9. PubMed ID: 22396164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
